NEXTGEN HEALTHCARE INC (NXGN) Stock Fundamental Analysis

NASDAQ:NXGN • US65343C1027

23.94 USD
+0.03 (+0.13%)
At close: Nov 8, 2023
23.93 USD
-0.01 (-0.04%)
After Hours: 11/8/2023, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, NXGN scores 4 out of 10 in our fundamental rating. NXGN was compared to 35 industry peers in the Health Care Technology industry. NXGN has only an average score on both its financial health and profitability. NXGN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • NXGN had positive earnings in the past year.
  • NXGN had a negative operating cash flow in the past year.
  • Of the past 5 years NXGN 4 years were profitable.
  • Each year in the past 5 years NXGN had a positive operating cash flow.
NXGN Yearly Net Income VS EBIT VS OCF VS FCFNXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

1.2 Ratios

  • With a decent Return On Assets value of -0.72%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • With a decent Return On Equity value of -1.47%, NXGN is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • The Return On Invested Capital of NXGN (0.82%) is better than 78.57% of its industry peers.
  • NXGN had an Average Return On Invested Capital over the past 3 years of 1.91%. This is below the industry average of 6.72%.
Industry RankSector Rank
ROA -0.72%
ROE -1.47%
ROIC 0.82%
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
NXGN Yearly ROA, ROE, ROICNXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.06%, NXGN is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • NXGN's Operating Margin has declined in the last couple of years.
  • NXGN has a Gross Margin of 46.40%. This is comparable to the rest of the industry: NXGN outperforms 42.86% of its industry peers.
  • In the last couple of years the Gross Margin of NXGN has declined.
Industry RankSector Rank
OM 1.06%
PM (TTM) N/A
GM 46.4%
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
NXGN Yearly Profit, Operating, Gross MarginsNXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • NXGN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for NXGN has been reduced compared to 1 year ago.
  • The debt/assets ratio for NXGN is higher compared to a year ago.
NXGN Yearly Shares OutstandingNXGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
NXGN Yearly Total Debt VS Total AssetsNXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

  • NXGN has an Altman-Z score of 3.59. This indicates that NXGN is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.59, NXGN is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • NXGN has a Debt/Equity ratio of 0.63. This is a neutral value indicating NXGN is somewhat dependend on debt financing.
  • NXGN has a worse Debt to Equity ratio (0.63) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 3.59
ROIC/WACC0.08
WACC10.14%
NXGN Yearly LT Debt VS Equity VS FCFNXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.52 indicates that NXGN has no problem at all paying its short term obligations.
  • NXGN's Current ratio of 2.52 is in line compared to the rest of the industry. NXGN outperforms 50.00% of its industry peers.
  • NXGN has a Quick Ratio of 2.52. This indicates that NXGN is financially healthy and has no problem in meeting its short term obligations.
  • NXGN has a Quick ratio (2.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 2.52
NXGN Yearly Current Assets VS Current LiabilitesNXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • NXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.33%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 6.96% on average over the past years.
  • Looking at the last year, NXGN shows a quite strong growth in Revenue. The Revenue has grown by 13.25% in the last year.
  • Measured over the past years, NXGN shows a small growth in Revenue. The Revenue has been growing by 4.23% on average per year.
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%

3.2 Future

  • NXGN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.15% yearly.
  • NXGN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.76% yearly.
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NXGN Yearly Revenue VS EstimatesNXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
NXGN Yearly EPS VS EstimatesNXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • NXGN is valuated rather expensively with a Price/Earnings ratio of 21.38.
  • Based on the Price/Earnings ratio, NXGN is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
  • NXGN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • With a Price/Forward Earnings ratio of 17.59, NXGN is valued on the expensive side.
  • 92.86% of the companies in the same industry are more expensive than NXGN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. NXGN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.38
Fwd PE 17.59
NXGN Price Earnings VS Forward Price EarningsNXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • NXGN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. NXGN is cheaper than 71.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 34.12
NXGN Per share dataNXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • NXGN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as NXGN's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)1.48
PEG (5Y)3.07
EPS Next 2Y17.83%
EPS Next 3Y17.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NXGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NEXTGEN HEALTHCARE INC

NASDAQ:NXGN (11/8/2023, 8:00:02 PM)

After market: 23.93 -0.01 (-0.04%)

23.94

+0.03 (+0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)10-24
Earnings (Next)01-22
Inst Owners0%
Inst Owner Change0%
Ins Owners31.12%
Ins Owner Change0%
Market Cap1.61B
Revenue(TTM)695.05M
Net Income(TTM)-6.21M
Analysts50.77
Price Target24.41 (1.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.71
Dividend Growth(5Y)3.39%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.08%
Min EPS beat(2)6.95%
Max EPS beat(2)23.21%
EPS beat(4)3
Avg EPS beat(4)7.54%
Min EPS beat(4)-6.17%
Max EPS beat(4)23.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2.26%
Max Revenue beat(2)0.72%
Revenue beat(4)2
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-2.26%
Max Revenue beat(4)2.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.11%
PT rev (3m)16.34%
EPS NQ rev (1m)-2.38%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)0%
EPS NY rev (3m)0.55%
Revenue NQ rev (1m)0.33%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 21.38
Fwd PE 17.59
P/S 2.31
P/FCF N/A
P/OCF N/A
P/B 3.8
P/tB 94.94
EV/EBITDA 34.12
EPS(TTM)1.12
EY4.68%
EPS(NY)1.36
Fwd EY5.68%
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS10.36
BVpS6.31
TBVpS0.25
PEG (NY)1.48
PEG (5Y)3.07
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.47%
ROCE 1.04%
ROIC 0.82%
ROICexc 1.14%
ROICexgc 5.45%
OM 1.06%
PM (TTM) N/A
GM 46.4%
FCFM N/A
ROA(3y)0.48%
ROA(5y)1.41%
ROE(3y)0.64%
ROE(5y)2.06%
ROIC(3y)1.91%
ROIC(5y)2.95%
ROICexc(3y)2.27%
ROICexc(5y)3.46%
ROICexgc(3y)18.71%
ROICexgc(5y)23.54%
ROCE(3y)2.41%
ROCE(5y)3.74%
ROICexgc growth 3Y-50.16%
ROICexgc growth 5Y-31.62%
ROICexc growth 3Y-56.26%
ROICexc growth 5Y-28.38%
OM growth 3Y-58.31%
OM growth 5Y-27.53%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5Y-2.66%
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA 5.98
Cap/Depr 95.52%
Cap/Sales 5.14%
Interest Coverage 1.1
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 2.52
Altman-Z 3.59
F-Score2
WACC10.14%
ROIC/WACC0.08
Cap/Depr(3y)75.15%
Cap/Depr(5y)68.18%
Cap/Sales(3y)5.17%
Cap/Sales(5y)5.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y5.69%
EPS 5Y6.96%
EPS Q2Q%24%
EPS Next Y14.49%
EPS Next 2Y17.83%
EPS Next 3Y17.28%
EPS Next 5Y17.15%
Revenue 1Y (TTM)13.25%
Revenue growth 3Y6.53%
Revenue growth 5Y4.23%
Sales Q2Q%10.65%
Revenue Next Year11.2%
Revenue Next 2Y9.22%
Revenue Next 3Y8.41%
Revenue Next 5Y7.76%
EBIT growth 1Y-70.75%
EBIT growth 3Y-55.58%
EBIT growth 5Y-24.47%
EBIT Next Year47.96%
EBIT Next 3Y27.47%
EBIT Next 5Y21.11%
FCF growth 1Y-203.01%
FCF growth 3Y-52.24%
FCF growth 5Y-32.4%
OCF growth 1Y-110.78%
OCF growth 3Y-20.1%
OCF growth 5Y-10.01%

NEXTGEN HEALTHCARE INC / NXGN FAQ

What is the fundamental rating for NXGN stock?

ChartMill assigns a fundamental rating of 4 / 10 to NXGN.


Can you provide the valuation status for NEXTGEN HEALTHCARE INC?

ChartMill assigns a valuation rating of 3 / 10 to NEXTGEN HEALTHCARE INC (NXGN). This can be considered as Overvalued.


What is the profitability of NXGN stock?

NEXTGEN HEALTHCARE INC (NXGN) has a profitability rating of 4 / 10.


What is the financial health of NEXTGEN HEALTHCARE INC (NXGN) stock?

The financial health rating of NEXTGEN HEALTHCARE INC (NXGN) is 4 / 10.


How sustainable is the dividend of NEXTGEN HEALTHCARE INC (NXGN) stock?

The dividend rating of NEXTGEN HEALTHCARE INC (NXGN) is 0 / 10 and the dividend payout ratio is 0%.